163 related articles for article (PubMed ID: 24990246)
1. TRAF4 participates in Wnt/β-catenin signaling in breast cancer by upregulating β-catenin and mediating its translocation to the nucleus.
Wang A; Wang J; Ren H; Yang F; Sun L; Diao K; Zhao Z; Song M; Cui Z; Wang E; Wei M; Mi X
Mol Cell Biochem; 2014 Oct; 395(1-2):211-9. PubMed ID: 24990246
[TBL] [Abstract][Full Text] [Related]
2. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
[TBL] [Abstract][Full Text] [Related]
3. TRAF2 regulates the cytoplasmic/nuclear distribution of TRAF4 and its biological function in breast cancer cells.
Zhang X; Wen Z; Sun L; Wang J; Song M; Wang E; Mi X
Biochem Biophys Res Commun; 2013 Jun; 436(2):344-8. PubMed ID: 23743189
[TBL] [Abstract][Full Text] [Related]
4. TRAF4, a new substrate of SIAH1, participates in chemotherapy resistance of breast cancer cell by counteracting SIAH1-mediated downregulation of β-catenin.
Ren H; Mi X; Zhao P; Zhao X; Wei N; Huang H; Meng Z; Kou J; Sun M; Liu Y; Zhang H; Yang J; Li W; Li H
Breast Cancer Res Treat; 2020 Sep; 183(2):275-289. PubMed ID: 32671611
[TBL] [Abstract][Full Text] [Related]
5. TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis.
Zhang L; Zhou F; García de Vinuesa A; de Kruijf EM; Mesker WE; Hui L; Drabsch Y; Li Y; Bauer A; Rousseau A; Sheppard KA; Mickanin C; Kuppen PJ; Lu CX; Ten Dijke P
Mol Cell; 2013 Sep; 51(5):559-72. PubMed ID: 23973329
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of proteins interacting with Traf4, an enigmatic p53 target.
Rozan LM; El-Deiry WS
Cancer Biol Ther; 2006 Sep; 5(9):1228-35. PubMed ID: 16969126
[TBL] [Abstract][Full Text] [Related]
7. Expression of tumor necrosis factor receptor-assicated factor 4 correlates with expression of Girdin and promotes nuclear translocation of Girdin in breast cancer.
Wang A; Wang J; Sun L; Jin J; Ren H; Yang F; Diao K; Wei M; Mi X
Mol Med Rep; 2015 May; 11(5):3635-41. PubMed ID: 25591657
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.
Zhu L; Zhang S; Huan X; Mei Y; Yang H
Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic TRAF4 contributes to the activation of p70s6k signaling pathway in breast cancer.
Ren HY; Wang J; Yang F; Zhang XL; Wang AL; Sun LL; Diao KX; Wang EH; Mi XY
Oncotarget; 2015 Feb; 6(6):4080-96. PubMed ID: 25738361
[TBL] [Abstract][Full Text] [Related]
10. Proliferative role of TRAF4 in breast cancer by upregulating PRMT5 nuclear expression.
Yang F; Wang J; Ren HY; Jin J; Wang AL; Sun LL; Diao KX; Wang EH; Mi XY
Tumour Biol; 2015 Aug; 36(8):5901-11. PubMed ID: 25704480
[TBL] [Abstract][Full Text] [Related]
11. TRAF4 promotes the growth and invasion of colon cancer through the Wnt/β-catenin pathway.
Yang K; Wang F; Han JJ
Int J Clin Exp Pathol; 2015; 8(2):1419-26. PubMed ID: 25973026
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.
Liu F; Liu Y; Shen J; Zhang G; Han J
Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393
[TBL] [Abstract][Full Text] [Related]
13. TRAF4 promotes tumorigenesis of breast cancer through activation of Akt.
Zhang J; Li X; Yang W; Jiang X; Li N
Oncol Rep; 2014 Sep; 32(3):1312-8. PubMed ID: 24993240
[TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of TRAF4 protein in breast carcinoma].
Dai WB; Zheng YW; Mi XY; Liu N; Lin H; Yan J
Ai Zheng; 2007 Oct; 26(10):1095-8. PubMed ID: 17927880
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitination of tumor necrosis factor receptor-associated factor 4 (TRAF4) by Smad ubiquitination regulatory factor 1 (Smurf1) regulates motility of breast epithelial and cancer cells.
Wang X; Jin C; Tang Y; Tang LY; Zhang YE
J Biol Chem; 2013 Jul; 288(30):21784-92. PubMed ID: 23760265
[TBL] [Abstract][Full Text] [Related]
16. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
18. Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways.
Yan D; Avtanski D; Saxena NK; Sharma D
J Biol Chem; 2012 Mar; 287(11):8598-612. PubMed ID: 22270359
[TBL] [Abstract][Full Text] [Related]
19. KRT19 directly interacts with β-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties.
Saha SK; Choi HY; Kim BW; Dayem AA; Yang GM; Kim KS; Yin YF; Cho SG
Oncogene; 2017 Jan; 36(3):332-349. PubMed ID: 27345400
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-receptor-associated factor-4 is a positive regulator of transforming growth factor-beta signaling that affects neural crest formation.
Kalkan T; Iwasaki Y; Park CY; Thomsen GH
Mol Biol Cell; 2009 Jul; 20(14):3436-50. PubMed ID: 19458200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
